The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B
Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue JCM About JCM Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Com...
Gespeichert in:
| Veröffentlicht in: | Journal of Clinical Microbiology 2011-05, Vol.49 (5), p.1853-1860 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1860 |
|---|---|
| container_issue | 5 |
| container_start_page | 1853 |
| container_title | Journal of Clinical Microbiology |
| container_volume | 49 |
| creator | ITO, Kiyoaki HIGAMI, Katsuya NOMURA, Hideyuki HIGE, Shuhei ADACHI, Hiroshi HINO, Keisuke YATSUHASHI, Hiroshi ORITO, Etsuro KANI, Satomi TANAKA, Yasuhito MIZOKAMI, Masashi MASAKI, Naohiko SUGIYAMA, Masaya MUKAIDE, Motokazu SAITO, Hiroaki AOKI, Yoshihiko SATO, Yo IMAMURA, Masatoshi MURATA, Kazumoto |
| description | Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
|
| doi_str_mv | 10.1128/JCM.02139-10 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_highw</sourceid><recordid>TN_cdi_highwire_asm_jcm_49_5_1853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1028075197</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-5cfb2cc1f83300ea35b2de83c940db7a77d72d2d7f47062a11f916cee4733b243</originalsourceid><addsrcrecordid>eNpVks9v0zAUxyMEYmVw44zMAYlDs_lH0sQXpK7A6LSxahuCm-U4L423xA62uyl_PZi1DHawbNmf9_2-Z32T5DXBB4TQ8vBkcXaAKWE8JfhJMiGYl-lshn88TSYY8zwlhBV7yQvvrzEmWZbnz5O9iJec5LNJ8uuqBeR8iTnnpEAr2429dUOrfT9F31sw6CMEcL02UKNqRBJdbnSQVQfoGIwN46DNGp1BaG09RUsfgSMIsQKtHNRaBetQE9cF-MEaDyhYtIL12MkQBefd0Eq0NJFvwFlzeKEreaudNij25eQwong8kYM0EGtXMmgwwaPQSoPOQ0TQZfSPzXzdqA5s0DU8msGjufdW6Xu3Ox3arVkHmxttUloevUyeNbLz8Gq37yffPn-6WnxJT8-Pl4v5aaqygoY0V01FlSJNyRjGIFle0RpKpniG66qQRVEXtKZ10WQFnlFJSMPJTAFkBWMVzdh-8mGrO2yqHmoVx3CyE4PTvXSjsFKLxy9Gt2JtbwUjlM54HgXe7wSc_bkBH0SvvYKui19jN14QTEtc5IQXEZ1uUeWs9w6aBxuCxZ_MiJgZcZ-ZeBPxN_-39gD_DUkE3u0A6ZXsGieN0v4flxGWlYxH7u2Wa_W6vdMOhPS9uFa9yLjIBSlzxn4DanPaZw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1028075197</pqid></control><display><type>article</type><title>The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B</title><source>American Society for Microbiology</source><source>MEDLINE</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>ITO, Kiyoaki ; HIGAMI, Katsuya ; NOMURA, Hideyuki ; HIGE, Shuhei ; ADACHI, Hiroshi ; HINO, Keisuke ; YATSUHASHI, Hiroshi ; ORITO, Etsuro ; KANI, Satomi ; TANAKA, Yasuhito ; MIZOKAMI, Masashi ; MASAKI, Naohiko ; SUGIYAMA, Masaya ; MUKAIDE, Motokazu ; SAITO, Hiroaki ; AOKI, Yoshihiko ; SATO, Yo ; IMAMURA, Masatoshi ; MURATA, Kazumoto</creator><creatorcontrib>ITO, Kiyoaki ; HIGAMI, Katsuya ; NOMURA, Hideyuki ; HIGE, Shuhei ; ADACHI, Hiroshi ; HINO, Keisuke ; YATSUHASHI, Hiroshi ; ORITO, Etsuro ; KANI, Satomi ; TANAKA, Yasuhito ; MIZOKAMI, Masashi ; MASAKI, Naohiko ; SUGIYAMA, Masaya ; MUKAIDE, Motokazu ; SAITO, Hiroaki ; AOKI, Yoshihiko ; SATO, Yo ; IMAMURA, Masatoshi ; MURATA, Kazumoto</creatorcontrib><description>Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/JCM.02139-10</identifier><identifier>PMID: 21389156</identifier><identifier>CODEN: JCMIDW</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Aged ; Antiviral Agents - administration & dosage ; Asian People ; Biological and medical sciences ; Drug Therapy, Combination - methods ; Female ; Fundamental and applied biological sciences. Psychology ; Genetic Testing - methods ; Genotype ; Genotyping ; Hepatitis C virus ; Hepatitis C, Chronic - drug therapy ; Humans ; Interferon-alpha - administration & dosage ; Interferons ; Interleukins - genetics ; Japan ; Male ; Microbiology ; Middle Aged ; Polymorphism, Single Nucleotide ; Prognosis ; Ribavirin - administration & dosage ; Treatment Outcome ; Virology</subject><ispartof>Journal of Clinical Microbiology, 2011-05, Vol.49 (5), p.1853-1860</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011, American Society for Microbiology 2011 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-5cfb2cc1f83300ea35b2de83c940db7a77d72d2d7f47062a11f916cee4733b243</citedby><cites>FETCH-LOGICAL-c472t-5cfb2cc1f83300ea35b2de83c940db7a77d72d2d7f47062a11f916cee4733b243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122695/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122695/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,3175,3176,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24134839$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21389156$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ITO, Kiyoaki</creatorcontrib><creatorcontrib>HIGAMI, Katsuya</creatorcontrib><creatorcontrib>NOMURA, Hideyuki</creatorcontrib><creatorcontrib>HIGE, Shuhei</creatorcontrib><creatorcontrib>ADACHI, Hiroshi</creatorcontrib><creatorcontrib>HINO, Keisuke</creatorcontrib><creatorcontrib>YATSUHASHI, Hiroshi</creatorcontrib><creatorcontrib>ORITO, Etsuro</creatorcontrib><creatorcontrib>KANI, Satomi</creatorcontrib><creatorcontrib>TANAKA, Yasuhito</creatorcontrib><creatorcontrib>MIZOKAMI, Masashi</creatorcontrib><creatorcontrib>MASAKI, Naohiko</creatorcontrib><creatorcontrib>SUGIYAMA, Masaya</creatorcontrib><creatorcontrib>MUKAIDE, Motokazu</creatorcontrib><creatorcontrib>SAITO, Hiroaki</creatorcontrib><creatorcontrib>AOKI, Yoshihiko</creatorcontrib><creatorcontrib>SATO, Yo</creatorcontrib><creatorcontrib>IMAMURA, Masatoshi</creatorcontrib><creatorcontrib>MURATA, Kazumoto</creatorcontrib><title>The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B</title><title>Journal of Clinical Microbiology</title><addtitle>J Clin Microbiol</addtitle><description>Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
</description><subject>Aged</subject><subject>Antiviral Agents - administration & dosage</subject><subject>Asian People</subject><subject>Biological and medical sciences</subject><subject>Drug Therapy, Combination - methods</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Testing - methods</subject><subject>Genotype</subject><subject>Genotyping</subject><subject>Hepatitis C virus</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Humans</subject><subject>Interferon-alpha - administration & dosage</subject><subject>Interferons</subject><subject>Interleukins - genetics</subject><subject>Japan</subject><subject>Male</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Prognosis</subject><subject>Ribavirin - administration & dosage</subject><subject>Treatment Outcome</subject><subject>Virology</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVks9v0zAUxyMEYmVw44zMAYlDs_lH0sQXpK7A6LSxahuCm-U4L423xA62uyl_PZi1DHawbNmf9_2-Z32T5DXBB4TQ8vBkcXaAKWE8JfhJMiGYl-lshn88TSYY8zwlhBV7yQvvrzEmWZbnz5O9iJec5LNJ8uuqBeR8iTnnpEAr2429dUOrfT9F31sw6CMEcL02UKNqRBJdbnSQVQfoGIwN46DNGp1BaG09RUsfgSMIsQKtHNRaBetQE9cF-MEaDyhYtIL12MkQBefd0Eq0NJFvwFlzeKEreaudNij25eQwong8kYM0EGtXMmgwwaPQSoPOQ0TQZfSPzXzdqA5s0DU8msGjufdW6Xu3Ox3arVkHmxttUloevUyeNbLz8Gq37yffPn-6WnxJT8-Pl4v5aaqygoY0V01FlSJNyRjGIFle0RpKpniG66qQRVEXtKZ10WQFnlFJSMPJTAFkBWMVzdh-8mGrO2yqHmoVx3CyE4PTvXSjsFKLxy9Gt2JtbwUjlM54HgXe7wSc_bkBH0SvvYKui19jN14QTEtc5IQXEZ1uUeWs9w6aBxuCxZ_MiJgZcZ-ZeBPxN_-39gD_DUkE3u0A6ZXsGieN0v4flxGWlYxH7u2Wa_W6vdMOhPS9uFa9yLjIBSlzxn4DanPaZw</recordid><startdate>20110501</startdate><enddate>20110501</enddate><creator>ITO, Kiyoaki</creator><creator>HIGAMI, Katsuya</creator><creator>NOMURA, Hideyuki</creator><creator>HIGE, Shuhei</creator><creator>ADACHI, Hiroshi</creator><creator>HINO, Keisuke</creator><creator>YATSUHASHI, Hiroshi</creator><creator>ORITO, Etsuro</creator><creator>KANI, Satomi</creator><creator>TANAKA, Yasuhito</creator><creator>MIZOKAMI, Masashi</creator><creator>MASAKI, Naohiko</creator><creator>SUGIYAMA, Masaya</creator><creator>MUKAIDE, Motokazu</creator><creator>SAITO, Hiroaki</creator><creator>AOKI, Yoshihiko</creator><creator>SATO, Yo</creator><creator>IMAMURA, Masatoshi</creator><creator>MURATA, Kazumoto</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20110501</creationdate><title>The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B</title><author>ITO, Kiyoaki ; HIGAMI, Katsuya ; NOMURA, Hideyuki ; HIGE, Shuhei ; ADACHI, Hiroshi ; HINO, Keisuke ; YATSUHASHI, Hiroshi ; ORITO, Etsuro ; KANI, Satomi ; TANAKA, Yasuhito ; MIZOKAMI, Masashi ; MASAKI, Naohiko ; SUGIYAMA, Masaya ; MUKAIDE, Motokazu ; SAITO, Hiroaki ; AOKI, Yoshihiko ; SATO, Yo ; IMAMURA, Masatoshi ; MURATA, Kazumoto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-5cfb2cc1f83300ea35b2de83c940db7a77d72d2d7f47062a11f916cee4733b243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aged</topic><topic>Antiviral Agents - administration & dosage</topic><topic>Asian People</topic><topic>Biological and medical sciences</topic><topic>Drug Therapy, Combination - methods</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Testing - methods</topic><topic>Genotype</topic><topic>Genotyping</topic><topic>Hepatitis C virus</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Humans</topic><topic>Interferon-alpha - administration & dosage</topic><topic>Interferons</topic><topic>Interleukins - genetics</topic><topic>Japan</topic><topic>Male</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Prognosis</topic><topic>Ribavirin - administration & dosage</topic><topic>Treatment Outcome</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ITO, Kiyoaki</creatorcontrib><creatorcontrib>HIGAMI, Katsuya</creatorcontrib><creatorcontrib>NOMURA, Hideyuki</creatorcontrib><creatorcontrib>HIGE, Shuhei</creatorcontrib><creatorcontrib>ADACHI, Hiroshi</creatorcontrib><creatorcontrib>HINO, Keisuke</creatorcontrib><creatorcontrib>YATSUHASHI, Hiroshi</creatorcontrib><creatorcontrib>ORITO, Etsuro</creatorcontrib><creatorcontrib>KANI, Satomi</creatorcontrib><creatorcontrib>TANAKA, Yasuhito</creatorcontrib><creatorcontrib>MIZOKAMI, Masashi</creatorcontrib><creatorcontrib>MASAKI, Naohiko</creatorcontrib><creatorcontrib>SUGIYAMA, Masaya</creatorcontrib><creatorcontrib>MUKAIDE, Motokazu</creatorcontrib><creatorcontrib>SAITO, Hiroaki</creatorcontrib><creatorcontrib>AOKI, Yoshihiko</creatorcontrib><creatorcontrib>SATO, Yo</creatorcontrib><creatorcontrib>IMAMURA, Masatoshi</creatorcontrib><creatorcontrib>MURATA, Kazumoto</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Clinical Microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ITO, Kiyoaki</au><au>HIGAMI, Katsuya</au><au>NOMURA, Hideyuki</au><au>HIGE, Shuhei</au><au>ADACHI, Hiroshi</au><au>HINO, Keisuke</au><au>YATSUHASHI, Hiroshi</au><au>ORITO, Etsuro</au><au>KANI, Satomi</au><au>TANAKA, Yasuhito</au><au>MIZOKAMI, Masashi</au><au>MASAKI, Naohiko</au><au>SUGIYAMA, Masaya</au><au>MUKAIDE, Motokazu</au><au>SAITO, Hiroaki</au><au>AOKI, Yoshihiko</au><au>SATO, Yo</au><au>IMAMURA, Masatoshi</au><au>MURATA, Kazumoto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B</atitle><jtitle>Journal of Clinical Microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>2011-05-01</date><risdate>2011</risdate><volume>49</volume><issue>5</issue><spage>1853</spage><epage>1860</epage><pages>1853-1860</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><coden>JCMIDW</coden><abstract>Article Usage Stats
Services
JCM
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
JCM
About
JCM
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
JCM
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0095-1137
Online ISSN:
1098-660X
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
JCM
.asm.org, visit:
JCM
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>21389156</pmid><doi>10.1128/JCM.02139-10</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0095-1137 |
| ispartof | Journal of Clinical Microbiology, 2011-05, Vol.49 (5), p.1853-1860 |
| issn | 0095-1137 1098-660X |
| language | eng |
| recordid | cdi_highwire_asm_jcm_49_5_1853 |
| source | American Society for Microbiology; MEDLINE; PubMed Central; EZB Electronic Journals Library |
| subjects | Aged Antiviral Agents - administration & dosage Asian People Biological and medical sciences Drug Therapy, Combination - methods Female Fundamental and applied biological sciences. Psychology Genetic Testing - methods Genotype Genotyping Hepatitis C virus Hepatitis C, Chronic - drug therapy Humans Interferon-alpha - administration & dosage Interferons Interleukins - genetics Japan Male Microbiology Middle Aged Polymorphism, Single Nucleotide Prognosis Ribavirin - administration & dosage Treatment Outcome Virology |
| title | The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T18%3A00%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_highw&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20rs8099917%20Polymorphism,%20When%20Determined%20by%20a%20Suitable%20Genotyping%20Method,%20Is%20a%20Better%20Predictor%20for%20Response%20to%20Pegylated%20Alpha%20Interferon/Ribavirin%20Therapy%20in%20Japanese%20Patients%20than%20Other%20Single%20Nucleotide%20Polymorphisms%20Associated%20with%20Interleukin-28B&rft.jtitle=Journal%20of%20Clinical%20Microbiology&rft.au=ITO,%20Kiyoaki&rft.date=2011-05-01&rft.volume=49&rft.issue=5&rft.spage=1853&rft.epage=1860&rft.pages=1853-1860&rft.issn=0095-1137&rft.eissn=1098-660X&rft.coden=JCMIDW&rft_id=info:doi/10.1128/JCM.02139-10&rft_dat=%3Cproquest_highw%3E1028075197%3C/proquest_highw%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1028075197&rft_id=info:pmid/21389156&rfr_iscdi=true |